TABLE 6 and 7: Microscopically verified

Percentage (%) of microscopically verified cases (persons)
Country average (population) Country average (country) England Scotland Northern Ireland Wales
All invasive xnmsc 84.8% 84.3% 85.1% 82.4% 85.7% 84.1%
All xnmsc 0-24 93.3% 95.5% 92.6% 99.3% 100.0% 90.1%
All xnmsc 25-59 96.2% 96.8% 96.0% 96.8% 97.5% 97.0%
All xnmsc 60-79 88.8% 88.3% 89.1% 85.9% 89.6% 88.4%
All xnmsc 80+ 62.3% 59.9% 63.0% 56.1% 59.3% 61.2%
All registrations 87.8% 82.1% 89.5% 88.3% 90.5% 60.1%
Haematology 87.0% 90.8% 85.9% 95.7% 92.8% 89.0%
Head and Neck 97.4% 97.5% 97.4% 96.5% 98.1% 98.1%
Lower GI 88.0% 88.0% 88.2% 86.9% 89.2% 87.7%
Upper GI 92.1% 92.1% 92.3% 90.8% 94.8% 90.7%
HPB 52.7% 49.9% 54.1% 41.5% 56.7% 47.2%
Trachea, Bronchus & Lung 68.8% 67.8% 69.5% 63.1% 69.6% 69.2%
Melanoma of skin 99.6% 99.7% 99.5% 99.8% 99.8% 99.8%
Breast 98.5% 98.3% 98.6% 98.3% 99.0% 97.5%
Cervix 97.9% 98.5% 97.8% 98.6% 100.0% 97.5%
Other Female Genitals 94.2% 93.7% 94.4% 93.1% 93.8% 93.6%
Prostate 86.8% 86.1% 87.0% 83.8% 85.1% 88.7%
Kidney 72.5% 71.5% 72.6% 73.9% 69.7% 69.6%
Bladder 89.8% 89.6% 90.0% 88.0% 90.7% 89.7%
Brain and CNS 68.2% 64.0% 69.1% 66.5% 58.5% 61.8%
Thyroid & other endocrine glands 96.6% 97.0% 96.5% 97.6% 97.7% 96.2%
CUP 44.5% 43.2% 45.3% 39.3% 47.0% 41.3%
Other invasive cancer 86.3% 84.5% 87.1% 78.2% 86.1% 86.8%
Breast in situ 99.9% 100.0% 99.9% 100.0% 100.0% 100.0%
Cervix in situ 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
Other tumours 87.8% 89.0% 87.0% 93.2% 89.7% 86.2%
Percentage (%) of non-specificity of morphology codes for cases which are microscopically verified
Country average (population) Country average (country) England Scotland Northern Ireland Wales
All invasive xnmsc 1.2% 1.1% 1.2% 0.9% 1.6% 0.7%
All xnmsc 0-24 0.7% 0.4% 0.8% 0.0% 0.8% 0.0%
All xnmsc 25-59 0.8% 0.7% 0.8% 0.7% 1.0% 0.5%
All xnmsc 60-79 1.1% 1.0% 1.1% 0.9% 1.4% 0.7%
All xnmsc 80+ 2.3% 2.2% 2.4% 1.7% 3.4% 1.4%
All registrations 1.2% 3.3% 0.9% 0.7% 10.8% 0.7%
Haematology 0.6% 0.6% 0.6% 0.6% 0.8% 0.3%
Head and Neck 1.0% 0.8% 1.0% 1.2% 1.1% 0.1%
Lower GI 1.0% 0.7% 1.1% 0.7% 0.3% 0.6%
Upper GI 1.0% 1.3% 0.9% 1.7% 1.3% 1.1%
HPB 4.4% 4.0% 4.6% 3.2% 5.2% 3.2%
Trachea, Bronchus & Lung 1.9% 1.7% 2.0% 1.5% 2.6% 0.7%
Melanoma of skin 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Breast 1.0% 1.1% 1.0% 0.6% 2.2% 0.7%
Cervix 0.6% 0.7% 0.5% 1.8% 0.0% 0.6%
Other Female Genitals 0.8% 0.6% 0.9% 0.6% 0.4% 0.6%
Prostate 0.5% 0.4% 0.6% 0.1% 0.4% 0.4%
Kidney 0.9% 0.6% 1.0% 0.4% 0.9% 0.2%
Bladder 0.9% 0.5% 1.0% 0.4% 0.5% 0.2%
Brain and CNS 0.4% 0.9% 0.4% 0.0% 3.2% 0.0%
Thyroid & other endocrine glands 1.9% 2.1% 1.8% 2.2% 2.4% 2.0%
CUP 14.9% 15.5% 15.1% 12.6% 23.8% 10.3%
Other invasive cancer 0.9% 0.9% 0.9% 0.9% 1.6% 0.2%
Breast in situ 0.0% 0.1% 0.0% 0.2% 0.0% 0.0%
Cervix in situ 3.5% 20.8% 0.3% 0.0% 82.7% 0.1%
Other tumours 3.4% 8.4% 1.9% 1.4% 30.0% 0.4%